335 related articles for article (PubMed ID: 37050968)
1. PROTOCOL: Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.
Strange CC; Manchak SM; Hyatt JM; Haberman C; Desai A
Campbell Syst Rev; 2021 Mar; 17(1):e1138. PubMed ID: 37050968
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.
Strange CC; Manchak SM; Hyatt JM; Petrich DM; Desai A; Haberman CP
Campbell Syst Rev; 2022 Mar; 18(1):e1215. PubMed ID: 36913194
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for opioid addiction in community corrections.
Schwartz RP; Mitchell MM; O'Grady KE; Kelly SM; Gryczynski J; Mitchell SG; Gordon MS; Jaffe JH
Int Rev Psychiatry; 2018 Oct; 30(5):117-135. PubMed ID: 30522370
[TBL] [Abstract][Full Text] [Related]
5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
6. Police-initiated diversion for youth to prevent future delinquent behavior: a systematic review.
Wilson DB; Brennan I; Olaghere A
Campbell Syst Rev; 2018; 14(1):1-88. PubMed ID: 37131366
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Psychological interventions for adults who have sexually offended or are at risk of offending.
Dennis JA; Khan O; Ferriter M; Huband N; Powney MJ; Duggan C
Cochrane Database Syst Rev; 2012 Dec; 12():CD007507. PubMed ID: 23235646
[TBL] [Abstract][Full Text] [Related]
9. Court personnel attitudes towards medication-assisted treatment: A state-wide survey.
Andraka-Christou B; Gabriel M; Madeira J; Silverman RD
J Subst Abuse Treat; 2019 Sep; 104():72-82. PubMed ID: 31370988
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for drug-using offenders.
Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217
[TBL] [Abstract][Full Text] [Related]
11. Criminal justice interventions for preventing radicalisation, violent extremism and terrorism: An evidence and gap map.
Sydes M; Hine L; Higginson A; McEwan J; Dugan L; Mazerolle L
Campbell Syst Rev; 2023 Dec; 19(4):e1366. PubMed ID: 38024779
[TBL] [Abstract][Full Text] [Related]
12. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
Booty MD; Harp K; Batty E; Knudsen HK; Staton M; Oser CB
J Subst Use Addict Treat; 2023 Jun; 149():209051. PubMed ID: 37084815
[TBL] [Abstract][Full Text] [Related]
13. Criminal justice continuum for opioid users at risk of overdose.
Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
[TBL] [Abstract][Full Text] [Related]
14. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
Friedmann PD; Hoskinson R; Gordon M; Schwartz R; Kinlock T; Knight K; Flynn PM; Welsh WN; Stein LA; Sacks S; O'Connell DJ; Knudsen HK; Shafer MS; Hall E; Frisman LK;
Subst Abus; 2012; 33(1):9-18. PubMed ID: 22263709
[TBL] [Abstract][Full Text] [Related]
15. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).
Maguire MJ; Jackson CF; Marson AG; Nolan SJ
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011792. PubMed ID: 27434597
[TBL] [Abstract][Full Text] [Related]
16. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
[TBL] [Abstract][Full Text] [Related]
17. The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study.
Binswanger IA; Nguyen AP; Morenoff JD; Xu S; Harding DJ
Addiction; 2020 Dec; 115(12):2329-2338. PubMed ID: 32267585
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.
Moore KE; Roberts W; Reid HH; Smith KMZ; Oberleitner LMS; McKee SA
J Subst Abuse Treat; 2019 Apr; 99():32-43. PubMed ID: 30797392
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis.
Bahji A; Carlone D; Altomare J
Addiction; 2020 Aug; 115(8):1413-1425. PubMed ID: 31863669
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
